Intercure Ltd. Logo

Intercure Ltd.

Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Intercure Ltd. is a pharmaceutical company focused on the medical cannabis sector. Its operations span research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis-based products. Operating under the brand name Canndoc, the company is recognized as a leading, profitable, and rapidly growing cannabis enterprise outside of North America. Intercure is dedicated to developing and providing high-quality, standardized cannabis products for medical use to patients and pharmacies globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 20:31
Foreign Filer Report
Immediate Report
English 322.0 KB
2025-10-08 20:31
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 473.8 KB
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 203.6 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 36.2 KB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 1.9 MB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 36.3 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 147.7 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 36.3 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 120.2 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 36.3 KB
2025-02-02 09:30
Pre-Annual General Meeting Information
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 215.3 KB
2025-02-02 09:30
Foreign Filer Report
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 36.3 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 121.9 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cellromax Science Co., Ltd. Logo
Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.
South Korea 471820
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celltrion, Inc. Logo
A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.
South Korea 068270
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea 083790
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea 261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea 052670
Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary RICHT

Talk to a Data Expert

Have a question? We'll get back to you promptly.